Natural Course of COVID-19 and Independent Predictors of Mortality

Background: During the SARS-CoV-2 pandemic, several biomarkers were shown to be helpful in determining the prognosis of COVID-19 patients. The aim of our study was to evaluate the prognostic value of N-terminal pro-Brain Natriuretic Peptide (NT-pro-BNP) in a cohort of patients with COVID-19. Methods...

Full description

Saved in:
Bibliographic Details
Published inBiomedicines Vol. 11; no. 3; p. 939
Main Authors Orlando, Luana, Bagnato, Gianluca, Ioppolo, Carmelo, Franzè, Maria Stella, Perticone, Maria, Versace, Antonio Giovanni, Sciacqua, Angela, Russo, Vincenzo, Cicero, Arrigo Francesco Giuseppe, De Gaetano, Alberta, Dattilo, Giuseppe, Fogacci, Federica, Tringali, Maria Concetta, Di Micco, Pierpaolo, Squadrito, Giovanni, Imbalzano, Egidio
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 01.03.2023
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: During the SARS-CoV-2 pandemic, several biomarkers were shown to be helpful in determining the prognosis of COVID-19 patients. The aim of our study was to evaluate the prognostic value of N-terminal pro-Brain Natriuretic Peptide (NT-pro-BNP) in a cohort of patients with COVID-19. Methods: One-hundred and seven patients admitted to the Covid Hospital of Messina University between June 2022 and January 2023 were enrolled in our study. The demographic, clinical, biochemical, instrumental, and therapeutic parameters were recorded. The primary outcome was in-hospital mortality. A comparison between patients who recovered and were discharged and those who died during the hospitalization was performed. The independent parameters associated with in-hospital death were assessed by multivariable analysis and a stepwise regression logistic model. Results: A total of 27 events with an in-hospital mortality rate of 25.2% occurred during our study. Those who died during hospitalization were older, with lower GCS and PaO2/FiO2 ratio, elevated D-dimer values, INR, creatinine values and shorter PT (prothrombin time). They had an increased frequency of diagnosis of heart failure (p < 0.0001) and higher NT-pro-BNP values. A multivariate logistic regression analysis showed that higher NT-pro-BNP values and lower PT and PaO2/FiO2 at admission were independent predictors of mortality during hospitalization. Conclusions: This study shows that NT-pro-BNP levels, PT, and PaO2/FiO2 ratio are independently associated with in-hospital mortality in subjects with COVID-19 pneumonia. Further longitudinal studies are warranted to confirm the results of this study.
AbstractList Background: During the SARS-CoV-2 pandemic, several biomarkers were shown to be helpful in determining the prognosis of COVID-19 patients. The aim of our study was to evaluate the prognostic value of N-terminal pro-Brain Natriuretic Peptide (NT-pro-BNP) in a cohort of patients with COVID-19. Methods: One-hundred and seven patients admitted to the Covid Hospital of Messina University between June 2022 and January 2023 were enrolled in our study. The demographic, clinical, biochemical, instrumental, and therapeutic parameters were recorded. The primary outcome was in-hospital mortality. A comparison between patients who recovered and were discharged and those who died during the hospitalization was performed. The independent parameters associated with in-hospital death were assessed by multivariable analysis and a stepwise regression logistic model. Results: A total of 27 events with an in-hospital mortality rate of 25.2% occurred during our study. Those who died during hospitalization were older, with lower GCS and PaO 2 /FiO 2 ratio, elevated D-dimer values, INR, creatinine values and shorter PT (prothrombin time). They had an increased frequency of diagnosis of heart failure ( p < 0.0001) and higher NT-pro-BNP values. A multivariate logistic regression analysis showed that higher NT-pro-BNP values and lower PT and PaO 2 /FiO 2 at admission were independent predictors of mortality during hospitalization. Conclusions: This study shows that NT-pro-BNP levels, PT, and PaO 2 /FiO 2 ratio are independently associated with in-hospital mortality in subjects with COVID-19 pneumonia. Further longitudinal studies are warranted to confirm the results of this study.
Background: During the SARS-CoV-2 pandemic, several biomarkers were shown to be helpful in determining the prognosis of COVID-19 patients. The aim of our study was to evaluate the prognostic value of N-terminal pro-Brain Natriuretic Peptide (NT-pro-BNP) in a cohort of patients with COVID-19. Methods: One-hundred and seven patients admitted to the Covid Hospital of Messina University between June 2022 and January 2023 were enrolled in our study. The demographic, clinical, biochemical, instrumental, and therapeutic parameters were recorded. The primary outcome was in-hospital mortality. A comparison between patients who recovered and were discharged and those who died during the hospitalization was performed. The independent parameters associated with in-hospital death were assessed by multivariable analysis and a stepwise regression logistic model. Results: A total of 27 events with an in-hospital mortality rate of 25.2% occurred during our study. Those who died during hospitalization were older, with lower GCS and PaO2/FiO2 ratio, elevated D-dimer values, INR, creatinine values and shorter PT (prothrombin time). They had an increased frequency of diagnosis of heart failure (p < 0.0001) and higher NT-pro-BNP values. A multivariate logistic regression analysis showed that higher NT-pro-BNP values and lower PT and PaO2/FiO2 at admission were independent predictors of mortality during hospitalization. Conclusions: This study shows that NT-pro-BNP levels, PT, and PaO2/FiO2 ratio are independently associated with in-hospital mortality in subjects with COVID-19 pneumonia. Further longitudinal studies are warranted to confirm the results of this study.
During the SARS-CoV-2 pandemic, several biomarkers were shown to be helpful in determining the prognosis of COVID-19 patients. The aim of our study was to evaluate the prognostic value of N-terminal pro-Brain Natriuretic Peptide (NT-pro-BNP) in a cohort of patients with COVID-19.BACKGROUNDDuring the SARS-CoV-2 pandemic, several biomarkers were shown to be helpful in determining the prognosis of COVID-19 patients. The aim of our study was to evaluate the prognostic value of N-terminal pro-Brain Natriuretic Peptide (NT-pro-BNP) in a cohort of patients with COVID-19.One-hundred and seven patients admitted to the Covid Hospital of Messina University between June 2022 and January 2023 were enrolled in our study. The demographic, clinical, biochemical, instrumental, and therapeutic parameters were recorded. The primary outcome was in-hospital mortality. A comparison between patients who recovered and were discharged and those who died during the hospitalization was performed. The independent parameters associated with in-hospital death were assessed by multivariable analysis and a stepwise regression logistic model.METHODSOne-hundred and seven patients admitted to the Covid Hospital of Messina University between June 2022 and January 2023 were enrolled in our study. The demographic, clinical, biochemical, instrumental, and therapeutic parameters were recorded. The primary outcome was in-hospital mortality. A comparison between patients who recovered and were discharged and those who died during the hospitalization was performed. The independent parameters associated with in-hospital death were assessed by multivariable analysis and a stepwise regression logistic model.A total of 27 events with an in-hospital mortality rate of 25.2% occurred during our study. Those who died during hospitalization were older, with lower GCS and PaO2/FiO2 ratio, elevated D-dimer values, INR, creatinine values and shorter PT (prothrombin time). They had an increased frequency of diagnosis of heart failure (p < 0.0001) and higher NT-pro-BNP values. A multivariate logistic regression analysis showed that higher NT-pro-BNP values and lower PT and PaO2/FiO2 at admission were independent predictors of mortality during hospitalization.RESULTSA total of 27 events with an in-hospital mortality rate of 25.2% occurred during our study. Those who died during hospitalization were older, with lower GCS and PaO2/FiO2 ratio, elevated D-dimer values, INR, creatinine values and shorter PT (prothrombin time). They had an increased frequency of diagnosis of heart failure (p < 0.0001) and higher NT-pro-BNP values. A multivariate logistic regression analysis showed that higher NT-pro-BNP values and lower PT and PaO2/FiO2 at admission were independent predictors of mortality during hospitalization.This study shows that NT-pro-BNP levels, PT, and PaO2/FiO2 ratio are independently associated with in-hospital mortality in subjects with COVID-19 pneumonia. Further longitudinal studies are warranted to confirm the results of this study.CONCLUSIONSThis study shows that NT-pro-BNP levels, PT, and PaO2/FiO2 ratio are independently associated with in-hospital mortality in subjects with COVID-19 pneumonia. Further longitudinal studies are warranted to confirm the results of this study.
Background: During the SARS-CoV-2 pandemic, several biomarkers were shown to be helpful in determining the prognosis of COVID-19 patients. The aim of our study was to evaluate the prognostic value of N-terminal pro-Brain Natriuretic Peptide (NT-pro-BNP) in a cohort of patients with COVID-19. Methods: One-hundred and seven patients admitted to the Covid Hospital of Messina University between June 2022 and January 2023 were enrolled in our study. The demographic, clinical, biochemical, instrumental, and therapeutic parameters were recorded. The primary outcome was in-hospital mortality. A comparison between patients who recovered and were discharged and those who died during the hospitalization was performed. The independent parameters associated with in-hospital death were assessed by multivariable analysis and a stepwise regression logistic model. Results: A total of 27 events with an in-hospital mortality rate of 25.2% occurred during our study. Those who died during hospitalization were older, with lower GCS and PaO[sub.2]/FiO[sub.2] ratio, elevated D-dimer values, INR, creatinine values and shorter PT (prothrombin time). They had an increased frequency of diagnosis of heart failure (p < 0.0001) and higher NT-pro-BNP values. A multivariate logistic regression analysis showed that higher NT-pro-BNP values and lower PT and PaO[sub.2]/FiO[sub.2] at admission were independent predictors of mortality during hospitalization. Conclusions: This study shows that NT-pro-BNP levels, PT, and PaO[sub.2]/FiO[sub.2] ratio are independently associated with in-hospital mortality in subjects with COVID-19 pneumonia. Further longitudinal studies are warranted to confirm the results of this study.
During the SARS-CoV-2 pandemic, several biomarkers were shown to be helpful in determining the prognosis of COVID-19 patients. The aim of our study was to evaluate the prognostic value of N-terminal pro-Brain Natriuretic Peptide (NT-pro-BNP) in a cohort of patients with COVID-19. One-hundred and seven patients admitted to the Covid Hospital of Messina University between June 2022 and January 2023 were enrolled in our study. The demographic, clinical, biochemical, instrumental, and therapeutic parameters were recorded. The primary outcome was in-hospital mortality. A comparison between patients who recovered and were discharged and those who died during the hospitalization was performed. The independent parameters associated with in-hospital death were assessed by multivariable analysis and a stepwise regression logistic model. A total of 27 events with an in-hospital mortality rate of 25.2% occurred during our study. Those who died during hospitalization were older, with lower GCS and PaO /FiO ratio, elevated D-dimer values, INR, creatinine values and shorter PT (prothrombin time). They had an increased frequency of diagnosis of heart failure ( < 0.0001) and higher NT-pro-BNP values. A multivariate logistic regression analysis showed that higher NT-pro-BNP values and lower PT and PaO /FiO at admission were independent predictors of mortality during hospitalization. This study shows that NT-pro-BNP levels, PT, and PaO /FiO ratio are independently associated with in-hospital mortality in subjects with COVID-19 pneumonia. Further longitudinal studies are warranted to confirm the results of this study.
Audience Academic
Author Dattilo, Giuseppe
Fogacci, Federica
Bagnato, Gianluca
Perticone, Maria
Cicero, Arrigo Francesco Giuseppe
Franzè, Maria Stella
De Gaetano, Alberta
Orlando, Luana
Imbalzano, Egidio
Ioppolo, Carmelo
Russo, Vincenzo
Di Micco, Pierpaolo
Tringali, Maria Concetta
Sciacqua, Angela
Squadrito, Giovanni
Versace, Antonio Giovanni
AuthorAffiliation 4 IRCCS Policlinico S. Orsola—Malpighi, Hypertension and Cardiovascular risk Research Center, DIMEC, University of Bologna, 40100 Bologna, Italy
1 Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy
3 Department of Medical Translational Sciences, Division of Cardiology, Monaldi Hospital, University of Campania “Luigi Vanvitelli”, 80100 Naples, Italy
2 Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, 88100 Catanzaro, Italy
5 Department of Medicine, PO Santa Maria delle Grazie Pozzuoli, 80100 Naples, Italy
AuthorAffiliation_xml – name: 3 Department of Medical Translational Sciences, Division of Cardiology, Monaldi Hospital, University of Campania “Luigi Vanvitelli”, 80100 Naples, Italy
– name: 2 Department of Medical and Surgical Sciences, University Magna Græcia of Catanzaro, 88100 Catanzaro, Italy
– name: 1 Department of Clinical and Experimental Medicine, University of Messina, 98125 Messina, Italy
– name: 4 IRCCS Policlinico S. Orsola—Malpighi, Hypertension and Cardiovascular risk Research Center, DIMEC, University of Bologna, 40100 Bologna, Italy
– name: 5 Department of Medicine, PO Santa Maria delle Grazie Pozzuoli, 80100 Naples, Italy
Author_xml – sequence: 1
  givenname: Luana
  surname: Orlando
  fullname: Orlando, Luana
– sequence: 2
  givenname: Gianluca
  orcidid: 0000-0002-7594-8520
  surname: Bagnato
  fullname: Bagnato, Gianluca
– sequence: 3
  givenname: Carmelo
  orcidid: 0000-0003-2918-3528
  surname: Ioppolo
  fullname: Ioppolo, Carmelo
– sequence: 4
  givenname: Maria Stella
  orcidid: 0000-0002-9815-5275
  surname: Franzè
  fullname: Franzè, Maria Stella
– sequence: 5
  givenname: Maria
  surname: Perticone
  fullname: Perticone, Maria
– sequence: 6
  givenname: Antonio Giovanni
  surname: Versace
  fullname: Versace, Antonio Giovanni
– sequence: 7
  givenname: Angela
  surname: Sciacqua
  fullname: Sciacqua, Angela
– sequence: 8
  givenname: Vincenzo
  orcidid: 0000-0002-9227-0360
  surname: Russo
  fullname: Russo, Vincenzo
– sequence: 9
  givenname: Arrigo Francesco Giuseppe
  orcidid: 0000-0002-4367-3884
  surname: Cicero
  fullname: Cicero, Arrigo Francesco Giuseppe
– sequence: 10
  givenname: Alberta
  surname: De Gaetano
  fullname: De Gaetano, Alberta
– sequence: 11
  givenname: Giuseppe
  orcidid: 0000-0002-6681-0183
  surname: Dattilo
  fullname: Dattilo, Giuseppe
– sequence: 12
  givenname: Federica
  surname: Fogacci
  fullname: Fogacci, Federica
– sequence: 13
  givenname: Maria Concetta
  surname: Tringali
  fullname: Tringali, Maria Concetta
– sequence: 14
  givenname: Pierpaolo
  orcidid: 0000-0002-8484-4598
  surname: Di Micco
  fullname: Di Micco, Pierpaolo
– sequence: 15
  givenname: Giovanni
  surname: Squadrito
  fullname: Squadrito, Giovanni
– sequence: 16
  givenname: Egidio
  orcidid: 0000-0003-2656-5467
  surname: Imbalzano
  fullname: Imbalzano, Egidio
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36979918$$D View this record in MEDLINE/PubMed
BookMark eNp9kktv1DAUhS3Uij7oP0AoEptuUuw4jmM2qEx5jFQoC2BrefwYPMrYg-1U6r_nhmlpp6qIpSSyv3uOz9U9QnshBovQS4LPKBX4zcLHtTVe-2AzIZhiQcUzdNg0Da8FZmLvwf8BOsl5heERhPakfY4OaCe4EKQ_RO-_qjImNVSzOKZsq-iq2dXP-UVNRKWCqebB2I2FVyjVtzRZlpjyhH2JqajBl5sXaN-pIduT2-8x-vHxw_fZ5_ry6tN8dn5Za8ZxqRnXTqlGNZR0bcOFpe1CM8cU6VmrTaOFNlZZ4jBmthdwhLtuIRreayBsT4_RfKtrolrJTfJrlW5kVF7-3YhpKVUqXg9WCoPBjRNlhGkxp73VzrDOYdL1WBkKWu-2WptxAY3UEA-asCO6exL8L7mM15Jg3HaUCFA4vVVI8fdoc5Frn7UdBhVsHLOEhA2brKeLv36ErqDZAXo1UYT1LabinloqSOCDi2CsJ1F5zlsKrpRP1NkTFCxj117DkDgP-zsFrx4m_RfxbgQAeLsFdIo5J-uk9kUVH6fgfoDEcho5-dTIQXH7qPhO_79lfwBnx9ta
CitedBy_id crossref_primary_10_3390_biomedicines11092473
crossref_primary_10_1016_j_jtha_2024_02_013
crossref_primary_10_3390_biomedicines12010004
crossref_primary_10_1186_s12879_023_08764_1
crossref_primary_10_12677_ACM_2024_142515
crossref_primary_10_3390_v15061235
Cites_doi 10.1111/apm.13210
10.1093/cvr/cvac125
10.1097/CCM.0000000000005337
10.1016/j.ijid.2021.03.008
10.31083/j.rcm2301028
10.7150/thno.48076
10.3390/medicina58040530
10.1136/bmjopen-2020-043651
10.1093/eurheartj/ehab368
10.1093/eurheartj/ehaa388
10.1007/s10528-022-10206-7
10.1038/s41569-020-00435-x
10.1002/ejhf.2605
10.2807/1560-7917.ES.2020.25.16.2000460
10.1093/ehjacc/zuab009
10.3390/jcm9092957
10.1136/bmjopen-2014-006812
10.1111/jth.14820
10.1136/heartjnl-2020-317322
10.1186/s12931-020-01352-w
10.3390/jcm9072244
10.1038/d41586-020-02599-5
10.1002/ehf2.13548
10.1097/CCM.0000000000002017
10.1161/CIRCULATIONAHA.118.035319
10.3389/fphys.2021.748972
10.1007/s00134-020-05991-x
10.1007/s10096-020-04138-6
10.1186/s12968-021-00841-1
10.3390/jcm12051849
10.1016/S2213-2600(20)30076-X
10.4103/jrms.JRMS_1195_20
10.1097/HJH.0000000000003213
10.20944/preprints201901.0309.v1
10.1080/03007995.2020.1853510
10.3389/fmed.2021.719976
10.1038/s41598-021-86676-3
10.1007/s10741-020-10037-x
10.1016/j.ijcard.2020.09.048
10.1038/s41591-021-01630-0
10.1016/j.imlet.2021.04.007
ContentType Journal Article
Copyright COPYRIGHT 2023 MDPI AG
2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 by the authors. 2023
Copyright_xml – notice: COPYRIGHT 2023 MDPI AG
– notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 by the authors. 2023
DBID AAYXX
CITATION
NPM
8FE
8FH
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
COVID
DWQXO
GNUQQ
HCIFZ
LK8
M7P
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.3390/biomedicines11030939
DatabaseName CrossRef
PubMed
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
ProQuest Central Student
SciTech Premium Collection
ProQuest Biological Science Collection
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Biological Science Collection
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
Biological Science Database
ProQuest SciTech Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Academic UKI Edition
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
MEDLINE - Academic

PubMed
CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 2227-9059
ExternalDocumentID oai_doaj_org_article_9d07cf71ad9d40738ecfd56f01680ad3
PMC10046319
A743463379
36979918
10_3390_biomedicines11030939
Genre Journal Article
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID 53G
5VS
8FE
8FH
AADQD
AAFWJ
AAYXX
ACPRK
ADBBV
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
CITATION
EMOBN
GROUPED_DOAJ
GX1
HCIFZ
HYE
IAO
IHR
INH
ITC
KQ8
LK8
M7P
MODMG
M~E
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PROAC
RPM
NPM
PMFND
ABUWG
AZQEC
COVID
DWQXO
GNUQQ
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c570t-57cfaa2a23164279e34bc5f5a1854cd2c9cdeae1f005e89c5f066b9278c185e83
IEDL.DBID BENPR
ISSN 2227-9059
IngestDate Wed Aug 27 01:31:49 EDT 2025
Thu Aug 21 18:38:14 EDT 2025
Fri Jul 11 09:08:56 EDT 2025
Fri Jul 25 12:05:29 EDT 2025
Fri May 23 01:41:14 EDT 2025
Tue Jun 10 21:25:15 EDT 2025
Thu Jan 02 22:52:03 EST 2025
Thu Apr 24 23:00:58 EDT 2025
Tue Jul 01 03:17:33 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords COVID-19
NT-pro-BNP
SARS-CoV-2
biomarkers
prothrombin time
coronavirus disease
PaO2/FiO2
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c570t-57cfaa2a23164279e34bc5f5a1854cd2c9cdeae1f005e89c5f066b9278c185e83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4367-3884
0000-0002-9227-0360
0000-0002-8484-4598
0000-0003-2656-5467
0000-0003-2918-3528
0000-0002-7594-8520
0000-0002-9815-5275
0000-0002-6681-0183
OpenAccessLink https://www.proquest.com/docview/2791584039?pq-origsite=%requestingapplication%
PMID 36979918
PQID 2791584039
PQPubID 2032426
ParticipantIDs doaj_primary_oai_doaj_org_article_9d07cf71ad9d40738ecfd56f01680ad3
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10046319
proquest_miscellaneous_2792507388
proquest_journals_2791584039
gale_infotracmisc_A743463379
gale_infotracacademiconefile_A743463379
pubmed_primary_36979918
crossref_citationtrail_10_3390_biomedicines11030939
crossref_primary_10_3390_biomedicines11030939
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-03-01
PublicationDateYYYYMMDD 2023-03-01
PublicationDate_xml – month: 03
  year: 2023
  text: 2023-03-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Biomedicines
PublicationTitleAlternate Biomedicines
PublicationYear 2023
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Wungu (ref_11) 2021; 105
Stefanini (ref_30) 2020; 106
Hermansyah (ref_32) 2021; 53
Ammirati (ref_23) 2018; 138
Bonaccorsi (ref_20) 2021; 234
Evans (ref_33) 2021; 49
Arachchillage (ref_41) 2020; 18
Pepera (ref_1) 2022; 23
Xu (ref_10) 2020; 8
Ruan (ref_9) 2020; 46
Adeghate (ref_19) 2021; 26
ref_34
Santus (ref_37) 2020; 10
Batta (ref_7) 2021; 12
Bagnato (ref_40) 2021; 8
Gu (ref_39) 2021; 11
ref_18
Xie (ref_12) 2022; 60
ref_15
Finocchi (ref_2) 2022; 130
Aeschlimann (ref_6) 2021; 23
Yang (ref_26) 2021; 326
Vukomanovic (ref_5) 2021; 26
Sangaralingham (ref_25) 2023; 118
Tossetta (ref_4) 2022; 40
Villar (ref_35) 2015; 5
Feiner (ref_36) 2017; 45
Colaneri (ref_38) 2020; 25
Datta (ref_14) 2020; 10
Yoo (ref_31) 2021; 8
ref_24
Mueller (ref_8) 2021; 10
Ammirati (ref_21) 2021; 18
Gao (ref_28) 2020; 21
ref_42
Inciardi (ref_29) 2020; 41
Beyerstedt (ref_13) 2021; 40
McDonagh (ref_16) 2021; 42
Gulizia (ref_22) 2022; 24
ref_27
Patone (ref_17) 2022; 28
Baranovskii (ref_43) 2021; 37
Marshall (ref_3) 2020; 585
References_xml – volume: 130
  start-page: 243
  year: 2022
  ident: ref_2
  article-title: Could SARS-CoV-2 infection affect male fertility and sexuality?
  publication-title: APMIS
  doi: 10.1111/apm.13210
– volume: 118
  start-page: 3416
  year: 2023
  ident: ref_25
  article-title: Natriuretic peptide pathways in heart failure: Further therapeutic possibilities
  publication-title: Cardiovasc. Res.
  doi: 10.1093/cvr/cvac125
– volume: 49
  start-page: e1063
  year: 2021
  ident: ref_33
  article-title: Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021
  publication-title: Crit. Care Med.
  doi: 10.1097/CCM.0000000000005337
– volume: 105
  start-page: 551
  year: 2021
  ident: ref_11
  article-title: Meta-analysis of cardiac markers for predictive factors on severity and mortality of COVID-19
  publication-title: Int. J. Infect. Dis.
  doi: 10.1016/j.ijid.2021.03.008
– volume: 23
  start-page: 28
  year: 2022
  ident: ref_1
  article-title: Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: A systematic review
  publication-title: Rev. Cardiovasc. Med.
  doi: 10.31083/j.rcm2301028
– volume: 10
  start-page: 7448
  year: 2020
  ident: ref_14
  article-title: SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
  publication-title: Theranostics
  doi: 10.7150/thno.48076
– ident: ref_34
– ident: ref_18
  doi: 10.3390/medicina58040530
– volume: 10
  start-page: e043651
  year: 2020
  ident: ref_37
  article-title: Severity of respiratory failure at admission and in-hospital mortality in patients with COVID-19: A prospective observational multicentre study
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2020-043651
– volume: 42
  start-page: 3599
  year: 2021
  ident: ref_16
  article-title: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/ehab368
– volume: 41
  start-page: 1821
  year: 2020
  ident: ref_29
  article-title: Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/ehaa388
– volume: 60
  start-page: 2052
  year: 2022
  ident: ref_12
  article-title: Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2
  publication-title: Biochem. Genet.
  doi: 10.1007/s10528-022-10206-7
– volume: 18
  start-page: 169
  year: 2021
  ident: ref_21
  article-title: Myocarditis and inflammatory cardiomyopathy: Current evidence and future directions
  publication-title: Nat. Rev. Cardiol.
  doi: 10.1038/s41569-020-00435-x
– volume: 24
  start-page: 2078
  year: 2022
  ident: ref_22
  article-title: BLITZ-HF: A nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines
  publication-title: Eur. J. Heart Fail
  doi: 10.1002/ejhf.2605
– volume: 25
  start-page: 2000460
  year: 2020
  ident: ref_38
  article-title: Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020
  publication-title: Euro. Surveill.
  doi: 10.2807/1560-7917.ES.2020.25.16.2000460
– volume: 10
  start-page: 310
  year: 2021
  ident: ref_8
  article-title: Cardiovascular biomarkers in patients with COVID-19
  publication-title: Eur. Heart J. Acute Cardiovasc. Care
  doi: 10.1093/ehjacc/zuab009
– ident: ref_27
  doi: 10.3390/jcm9092957
– volume: 5
  start-page: e006812
  year: 2015
  ident: ref_35
  article-title: Assessment of PaO(2)/FiO(2) for stratification of patients with moderate and severe acute respiratory distress syndrome
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2014-006812
– volume: 18
  start-page: 1233
  year: 2020
  ident: ref_41
  article-title: Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
  publication-title: J. Thromb. Haemost.
  doi: 10.1111/jth.14820
– volume: 106
  start-page: 1512
  year: 2020
  ident: ref_30
  article-title: Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19
  publication-title: Heart
  doi: 10.1136/heartjnl-2020-317322
– volume: 21
  start-page: 83
  year: 2020
  ident: ref_28
  article-title: Prognostic value of NT-proBNP in patients with severe COVID-19
  publication-title: Respir. Res.
  doi: 10.1186/s12931-020-01352-w
– ident: ref_42
  doi: 10.3390/jcm9072244
– volume: 585
  start-page: 342
  year: 2020
  ident: ref_3
  article-title: How COVID-19 can damage the brain
  publication-title: Nature
  doi: 10.1038/d41586-020-02599-5
– volume: 8
  start-page: 4278
  year: 2021
  ident: ref_31
  article-title: Admission NT-proBNP and outcomes in patients without history of heart failure hospitalized with COVID-19
  publication-title: ESC Heart Fail
  doi: 10.1002/ehf2.13548
– volume: 45
  start-page: e40
  year: 2017
  ident: ref_36
  article-title: Evaluating Pulmonary Function: An Assessment of PaO2/FIO2
  publication-title: Crit. Care Med.
  doi: 10.1097/CCM.0000000000002017
– volume: 138
  start-page: 1088
  year: 2018
  ident: ref_23
  article-title: Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.118.035319
– volume: 12
  start-page: 748972
  year: 2021
  ident: ref_7
  article-title: Sequelae and Comorbidities of COVID-19 Manifestations on the Cardiac and the Vascular Systems
  publication-title: Front. Physiol.
  doi: 10.3389/fphys.2021.748972
– volume: 46
  start-page: 846
  year: 2020
  ident: ref_9
  article-title: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
  publication-title: Intensive Care Med.
  doi: 10.1007/s00134-020-05991-x
– volume: 40
  start-page: 905
  year: 2021
  ident: ref_13
  article-title: COVID-19: Angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
  publication-title: Eur. J. Clin. Microbiol. Infect. Dis.
  doi: 10.1007/s10096-020-04138-6
– volume: 23
  start-page: 140
  year: 2021
  ident: ref_6
  article-title: Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: A cardiovascular magnetic resonance based multicenter international study-the CARDOVID registry
  publication-title: J. Cardiovasc. Magn. Reson.
  doi: 10.1186/s12968-021-00841-1
– ident: ref_24
  doi: 10.3390/jcm12051849
– volume: 8
  start-page: 420
  year: 2020
  ident: ref_10
  article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome
  publication-title: Lancet Respir. Med.
  doi: 10.1016/S2213-2600(20)30076-X
– volume: 26
  start-page: 113
  year: 2021
  ident: ref_5
  article-title: Myocardial damage in multisystem inflammatory syndrome associated with COVID-19 in children and adolescents
  publication-title: J. Res. Med. Sci.
  doi: 10.4103/jrms.JRMS_1195_20
– volume: 40
  start-page: 1629
  year: 2022
  ident: ref_4
  article-title: Preeclampsia and severe acute respiratory syndrome coronavirus 2 infection: A systematic review
  publication-title: J. Hypertens.
  doi: 10.1097/HJH.0000000000003213
– ident: ref_15
  doi: 10.20944/preprints201901.0309.v1
– volume: 37
  start-page: 21
  year: 2021
  ident: ref_43
  article-title: Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia
  publication-title: Curr. Med. Res. Opin.
  doi: 10.1080/03007995.2020.1853510
– volume: 8
  start-page: 719976
  year: 2021
  ident: ref_40
  article-title: The COVID-19 Assessment for Survival at Admission (CASA) Index: A 12 Months Observational Study
  publication-title: Front. Med. (Lausanne)
  doi: 10.3389/fmed.2021.719976
– volume: 11
  start-page: 7334
  year: 2021
  ident: ref_39
  article-title: PaO(2)/FiO(2) and IL-6 are risk factors of mortality for intensive care COVID-19 patients
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-021-86676-3
– volume: 26
  start-page: 363
  year: 2021
  ident: ref_19
  article-title: Mechanisms of COVID-19-induced heart failure: A short review
  publication-title: Heart Fail Rev.
  doi: 10.1007/s10741-020-10037-x
– volume: 326
  start-page: 230
  year: 2021
  ident: ref_26
  article-title: Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia
  publication-title: Int. J. Cardiol.
  doi: 10.1016/j.ijcard.2020.09.048
– volume: 53
  start-page: 385
  year: 2021
  ident: ref_32
  article-title: Elevation of Cardiac Biomarkers in COVID-19 as a Major Determinant for Mortality: A Systematic Review
  publication-title: Acta Med. Indones.
– volume: 28
  start-page: 410
  year: 2022
  ident: ref_17
  article-title: Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection
  publication-title: Nat. Med.
  doi: 10.1038/s41591-021-01630-0
– volume: 234
  start-page: 44
  year: 2021
  ident: ref_20
  article-title: HLA-C*17 in COVID-19 patients: Hints for associations with severe clinical outcome and cardiovascular risk
  publication-title: Immunol. Lett.
  doi: 10.1016/j.imlet.2021.04.007
SSID ssj0000913814
Score 2.2472515
Snippet Background: During the SARS-CoV-2 pandemic, several biomarkers were shown to be helpful in determining the prognosis of COVID-19 patients. The aim of our study...
During the SARS-CoV-2 pandemic, several biomarkers were shown to be helpful in determining the prognosis of COVID-19 patients. The aim of our study was to...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 939
SubjectTerms biomarkers
Brain natriuretic peptide
Cardiovascular disease
Congestive heart failure
Coronaviruses
COVID-19
Creatinine
Mortality
NT-pro-BNP
PaO2/FiO2
Patients
Prothrombin
prothrombin time
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQT3BAQPlYKCiVKnGyGsdOYh_bQtVWauFAUW-WvyKQUBZ1t_-fN04aJQKpF67xRLHHM543sf2GsQMkyUI5WfIuCslViJ5703reBCQHZVBeBfoPeXnVnF2ri5v6Zlbqi86EDfTAg-IOTSyJOUe4aCKSD6lT6GLddIAqunQx83wi5s2SqbwGG4FQpIa7chJ5_eFwmz3vVm-EyBuAZhGLMmX_3wvzLDItT03OwtDpM_Z0xI_F0dDv5-xR6l-wJzNWwV12fOUymUZB9eg2qVh3xcmX7-efuDCF62NxPlW-3RZfb6m3VHGHxC4zFgcuf8muTz9_OznjY6kEHuq23PIaOnKuckBrSChak6Tyoe5qh3CMCaiCCTG5JDo4XdIGTYAa3lStDpBIWr5iO_26T29YoXUspcNEtQGraNDOBQ-Nq7bUvoqpXjF5rzQbRh5xKmfxyyKfIFXbf6l6xfj01u-BR-MB-WOaj0mWWLDzA9iGHW3DPmQbK_aRZtOSr6KLwY1XDjBQYr2yR4BPqpGyxef2FpLwsbBsvrcHO_r4xkLNAvCtpM7uT830Jp1b69P6LssAY6JnesVeD-YzDUk2tKUq0KIXhrUY87Kl__kjM4ATzV-DxfPt_9DSO_a4AnIbDtbtsZ3t7V16D6S19R-yU_0BtdInkw
  priority: 102
  providerName: Directory of Open Access Journals
Title Natural Course of COVID-19 and Independent Predictors of Mortality
URI https://www.ncbi.nlm.nih.gov/pubmed/36979918
https://www.proquest.com/docview/2791584039
https://www.proquest.com/docview/2792507388
https://pubmed.ncbi.nlm.nih.gov/PMC10046319
https://doaj.org/article/9d07cf71ad9d40738ecfd56f01680ad3
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagvcABUZ6BUgUJiZPVOHZi-4S6pVWL1KVCFPVmObZTkFBSdrf_nxnHGzaiaq87E63t8Txtf0PIB0iSmbC8oK1nnArnG9po2dDaQXJQONEIh3XIs3l9ciG-XFaXqeC2TNcq1zYxGmrfO6yR75dSM3CWBdefrv9Q7BqFp6uphcZDsg0mWEHytT07mp9_G6ssiHqpmBjezHHI7_eHV-3x1HrJWDwI1BOfFKH7_zfQGx5qentywx0dPyVPUhyZHwyC3yEPQveMPN5AF3xOZnMbQTVy7Eu3DHnf5odff5x-pkzntvP56dgBd5WfL3C02HkH2c5iTA7x-QtycXz0_fCEppYJ1FWyWNFKutba0kLUBomF1IGLxlVtZcEtgyBKp50PNrAWlC8oDSQIORpdSuWAIyj-kmx1fRdek1wpX3ALApMOrKlT1rqm9ZWQhWpKH6qM8PWiGZfwxLGtxW8DeQUutbltqTNCx6-uBzyNe_hnKI-RF9Gw4w_94sok5TLaF4iuxKzXHhJUroKDkdYthLOqsJ5n5CNK06DOwhCdTU8PYKKIfmUOIIwSNecS_m53wgm65qbk9X4wSdeX5t_OzMj7kYxf4v21LvQ3kQdiTRiZysirYfuMU-I1Hq0yoKjJxprMeUrpfv2MSOAI91eDEX1z97jekkclxGbD1bldsrVa3IR3EEutmr2kMHuxFvEXUuMg9w
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6V7QE4IN4ECgQJxMlqHOdhHxDq9qFd2l0q1KLeUsd2AAklZXcrxJ_iNzKTFxuB4NRrZpKM7fE8_PgG4CUmyTzSImCF5YJFxuYsV2nOEoPJQWCiPDK0DjmbJ5PT6N1ZfLYBP7u7MHSssrOJtaG2laE18u0wVRydZSDU24tvjKpG0e5qV0KjUYtD9-M7pmzLN9M9HN9XYXiwf7I7YW1VAWbiNFixODWF1qHGwAZj71Q5EeUmLmKNngtlDY0y1mnHC9RPJxWS0CvnKkylQQ4nBX73GmxGAlOZEWyO9-fHH_pVHULZlDxq7ugJoYLt5hZ9vUu-5LzeeFQDH1iXCvjTIax5xOFpzTX3d3AbbrVxq7_TKNod2HDlXbi5hmZ4D8ZzXYN4-FQHb-n8qvB333-c7jGufF1af9pX3F35xwuSlir9ENuszgEwH7gPp1fSmQ9gVFalewS-lDYQGhUkNWi9jdTa5IWNozSQeWhd7IHoOi0zLX45ldH4mmEeQ12d_a2rPWD9WxcNfsd_-Mc0Hj0voW_XD6rFp6ydzJmyAaE5cW2VxYRYSGdQ0qTA8FkG2goPXtNoZmQjUESj26sO2FBC28p2MGyLEiFS_N3WgBPnthmSO33IWtuyzH7PBA9e9GR6k87Lla66rHkwtkXJpAcPG_XpmyQS2srlSJEDxRq0eUgpv3yukccJXjBBo_3433I9h-uTk9lRdjSdHz6BGyHGhc2xvS0YrRaX7inGcav8WTt5fDi_6vn6Cx4sXRU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw8DQ6CcED4pvAgCCBeIoax0lsPyC0rqtWxkqFGNpb5tgOm4SS0XZC_DV-HXdJGhqB4GmvuUtytu_TPt8BvMQgmcWah0FhGQ9iY_MgVyIPUoPBQWjiPDa0D3k0Sw-O43cnyckW_FzfhaG0yrVOrBW1rQztkQ8joRgay5CrYdGmRczHk7cX3wLqIEUnret2Gg2LHLof3zF8W76ZjnGtX0XRZP_T3kHQdhgITCLCVZAIU2gdaXRy0A8XyvE4N0mRaLRiSHdklLFOO1YgrzqpEIQWOleRkAYxnOT43WuwLTAqCgewPdqfzT92OzxUcVOyuLmvx7kKh82N-vrEfMlYfQipevawbhvwp3HYsI79zM0NUzi5DbdaH9bfbZjuDmy58i7c3KhseA9GM10X9PCpJ97S-VXh7334PB0HTPm6tP6067678ucLopa6_hDaUR0PYGxwH46vZDIfwKCsSvcIfCltyDUyizCoyY3U2uSFTWIRyjyyLvGAryctM20tc2qp8TXDmIamOvvbVHsQdG9dNLU8_oM_ovXocKkSd_2gWnzJWsHOlA2pshPTVllkAy6dQUrTAl1pGWrLPXhNq5mRvkASjW6vPeBAqfJWtosuXJxyLvB3Oz1MlHPTB6_5IWv1zDL7LRUevOjA9CblzpWuuqxx0M9FyqQHDxv26YbEUzrWZQiRPcbqjbkPKc_P6irkVGowRQX--N90PYfrKKfZ--ns8AnciNBFbDL4dmCwWly6p-jSrfJnrez4cHrV4voLRpthSg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Natural+Course+of+COVID-19+and+Independent+Predictors+of+Mortality&rft.jtitle=Biomedicines&rft.au=Orlando%2C+Luana&rft.au=Bagnato%2C+Gianluca&rft.au=Ioppolo%2C+Carmelo&rft.au=Franz%C3%A8%2C+Maria+Stella&rft.date=2023-03-01&rft.pub=MDPI+AG&rft.eissn=2227-9059&rft.volume=11&rft.issue=3&rft.spage=939&rft_id=info:doi/10.3390%2Fbiomedicines11030939&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2227-9059&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2227-9059&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2227-9059&client=summon